Ampio Pharm Stock Market Value
| AMPE Stock | USD 0.01 0.00 0.00% |
| Symbol | Ampio |
Ampio Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ampio Pharm's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ampio Pharm.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Ampio Pharm on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Ampio Pharm or generate 0.0% return on investment in Ampio Pharm over 90 days. Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for t... More
Ampio Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ampio Pharm's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ampio Pharm upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 85.39 | |||
| Information Ratio | 0.3076 | |||
| Maximum Drawdown | 9998.31 | |||
| Value At Risk | (96.30) | |||
| Potential Upside | 3974.07 |
Ampio Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ampio Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ampio Pharm's standard deviation. In reality, there are many statistical measures that can use Ampio Pharm historical prices to predict the future Ampio Pharm's volatility.| Risk Adjusted Performance | 0.2579 | |||
| Jensen Alpha | 499.37 | |||
| Total Risk Alpha | 344.01 | |||
| Sortino Ratio | 5.94 | |||
| Treynor Ratio | 5.34 |
Ampio Pharm February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2579 | |||
| Market Risk Adjusted Performance | 5.35 | |||
| Mean Deviation | 907.05 | |||
| Semi Deviation | 51.08 | |||
| Downside Deviation | 85.39 | |||
| Coefficient Of Variation | 325.07 | |||
| Standard Deviation | 1647.94 | |||
| Variance | 2715695.44 | |||
| Information Ratio | 0.3076 | |||
| Jensen Alpha | 499.37 | |||
| Total Risk Alpha | 344.01 | |||
| Sortino Ratio | 5.94 | |||
| Treynor Ratio | 5.34 | |||
| Maximum Drawdown | 9998.31 | |||
| Value At Risk | (96.30) | |||
| Potential Upside | 3974.07 | |||
| Downside Variance | 7291.17 | |||
| Semi Variance | 2609.16 | |||
| Expected Short fall | (2,026) | |||
| Skewness | 3.94 | |||
| Kurtosis | 17.6 |
Ampio Pharm Backtested Returns
Ampio Pharm is out of control given 3 months investment horizon. Ampio Pharm secures Sharpe Ratio (or Efficiency) of 0.25, which signifies that the company had a 0.25 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 65.65% are justified by taking the suggested risk. Use Ampio Pharm Risk Adjusted Performance of 0.2579, mean deviation of 907.05, and Downside Deviation of 85.39 to evaluate company specific risk that cannot be diversified away. Ampio Pharm holds a performance score of 19 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 95.0, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ampio Pharm will likely underperform. Use Ampio Pharm sortino ratio and the relationship between the potential upside and day typical price , to analyze future returns on Ampio Pharm.
Auto-correlation | -0.04 |
Very weak reverse predictability
Ampio Pharm has very weak reverse predictability. Overlapping area represents the amount of predictability between Ampio Pharm time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ampio Pharm price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Ampio Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ampio Pink Sheet
Ampio Pharm financial ratios help investors to determine whether Ampio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ampio with respect to the benefits of owning Ampio Pharm security.